Angiotensin receptors: History and mysteries

American Journal of Hypertension

Volumn 13, Issue 4, 2000, Pages 442-449

  Goodfriend, Theodore L ^a,b  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Angiotensin; Cardiovascular diseases; Hypertension; Receptors

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN III; ANGIOTENSIN RECEPTOR; RECEPTOR SUBTYPE;

ASSAY; BINDING SITE; BLOOD CELL; BLOOD VESSEL; BRAIN REGION; CAT; DRUG RECEPTOR BINDING; ENDOCRINE GLAND; GONAD; HEART; HORMONE ACTION; HORMONE BINDING; HUMAN; KIDNEY; KINETICS; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RECEPTOR DENSITY; RECEPTOR GENE; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

HISTORY, 20TH CENTURY; HUMANS; HYPERTENSION, RENAL; PHYSIOLOGY; RECEPTORS, ANGIOTENSIN;

EID: 0034108612     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00212-5     Document Type: Review

References (55)

1. Ehrlich P: Chemotherapeutics: scientific principles, methods and results. Lancet 1913;2:445.
2. Langley JN: On nerve endings and on special excitable substances in cells. Proc R Soc Lond B Biol Sci 1906; B78:170.
3. Lin S-Y, Goodfriend TL: Angiotensin receptors. Am J Physiol 1970;218:1319-1328.
4. Goodfriend TL, Farley D, Ball DL: Radioimmunoassay of angiotensin. J Lab Clin Med 1968;72:648-662.
5. Bumpus FM, Smeby R, Page H, Khairallah PA: Distribution and metabolic fate of angiotensin II and various derivatives. Can Med Assoc J 1964;90:190-193.
6. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ: Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 1993;268:24539-24542.
7. Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T: Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type 1 receptor. Nature 1991;351: 230.
8. Phillips MI: Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension 1997;29:177-187.
9. Goodfriend TL, Lin S-Y: Receptors for angiotensin I and II. Circ Res 1970(suppl 26 and 27):I163-I174.
10. Mendelsohn FAO, Quirion R, Saavedra JM, Aguilera G, Catt KJ: Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci USA 1984;81: 1575.
11. Saavedra JM, Israel A, Plunkett LM, Kurihara M, Shigematsu K, Correa FMA: Quantitative distribution of angiotensin II binding sites in rat brain by autoradiography. Peptides 1986;7:679.
12. Goodfriend TG, Elliott ME, Catt KJ: Angiotensin receptors and their antagonists. N Engl J Med 1996;334:1649-1654.
13. Simpson RU, Campanile CP, Goodfriend TL: Specific inhibition of receptors for angiotensin II and angiotensin III in adrenal glomerulosa. Biochem Pharmacol 1980;29:927-933.
14. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JM, Smith RD: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45:205-251.
15. de Gasparo M, Husain A, Alexander W, Catt KJ, Chiu AT, Drew M, Goodfriend T, Harding JW, Inagami T, Timmermans PB: Proposed update of angiotensin receptor nomenclature. Hypertension 1995;25:924-927.
16. Goodfriend TL, Knych E, Allmann D, Kent K, Cooper T: Angiotensin binding to receptors - a guide to physiology and therapy, in Margoulies M, Greenwood FC (eds): Proceedings of the Second International Symposium, Structure-Activity Relationships of Protein and Polypeptide Hormones. Vol. 1. Excerpta Medica, Amsterdam, Liege, 1971, pp 243-249.
17. Kent KM, Goodfriend TL, McCallum ZT, Dempsey PJ, Cooper T: Inotropic agents in hypoxic cat myocardium: depression and potentiation. Circ Res 1972;30:196-204.
18. Goodfriend TL, Fyhrquist F, Gutmann F, Knych E, Hollemans H, Allmann D, Kent K, Cooper T: Clinical and conceptual uses of angiotensin receptors, in Genest J, Koiw K (eds): Hypertension '72, International Symposium on the Renin-Angiotensin-Aldosterone-Sodium System. Springer-Verlag, Mont. Gabriel, Quebec, Canada , 1972, pp 549-563.
19. Goodfriend T, Knych E, Lin S-Y, Henry R: Direct measurement of receptor binding-a screening procedure for angiotensin inhibitors (abstr). Clin Pharmacol Ther 1971;12:292.
20. Campanile CP, Goodfriend TL: Steroids as potential modulators of angiotensin receptors in bovine adrenal glomerulosa and kidney. Steroids 1981;37:681-700.
21. Simpson RU, Goodfriend TL: Angiotensin and prostaglandin interactions in cultured kidney tubules. J Lab Clin Med 1984;103:255-271.
22. Uehling D, Heber D, Goodfriend TL: Renal ischemia modified by an angiotensin-antagonist. Invest Urol 1974;11:345-346.
23. Kontogiannis J, Burns K: Role of AT1 angiotensin II receptors in renal ischemic injury. Am J Physiol 1998; 274:F79-F90.
24. Moore TJ, Williams GH: Angiotensin II receptors on human platelets. Circ Res 1982;51:314-320.
25. Siebers MJ, Goodfriend TL: Platelet angiotensin receptors in young and old humans. J Gerontol 1986;41:574-578.
26. Chabielska E, Pawlak R, Golatowski J, Buczko W: The antithrombotic effect of captopril and losartan on experimental arterial thrombosis in rats. J Physiol Pharmacol 1998;49:251-260.
27. Glossmann H, Baukal AJ, Catt KJ: Properties of angiotensin II receptors in the bovine and rat adrenal cortex. J Biol Chem 1974;249:825-834.
28. Carroll JE, Landry AS, Elliott ME, Goodfriend TL: Effects of pH on adrenal angiotensin receptors and responses. J Lab Clin Med 1986;108:23-29.
29. Goodfriend TL, Ball DL: Fatty acid effects on angiotensin receptors. J Cardiovasc Pharmacol 1986;8:1276-1283.
30. Goodfriend TL, Ball DL, Elliott ME, Chabhi A, Duong T, Raff H, Schneider EG, Brown RD, Weinberger MH: Fatty acids may regulate aldosterone secretion and mediate some of insulin's effects on blood pressure. Prostaglandins Leukot Essent Fatty Acids 1993;48:43-50.
31. Carroll JE, Landry AS, Elliott ME, Yatvin MB, Vorpahl J, Goodfriend TL: Cholesteryl hemisuccinate alters membrane fluidity, angiotensin receptors, and responses in adrenal glomerulosa cells. Life Sci 32:1573-1581.
32. Engler MM, Schambelan M, Engler MB, Ball DL, Goodfriend TL: Effects of dietary γ-linolenic acid on blood pressure and adrenal angiotensin receptors in hypertensive rats. Proc Soc Exp Biol Med 1998;218:234-237.
33. Carroll JE, Goodfriend TL: Androgen modulation of adrenal angiotensin receptors. Science 1984;224:1009-1011.
34. Hunyady L, Bor M, Balla T, Catt KJ: Identification of a cytoplasmic ser-thr-leu motif that determines agonist-induced internalization of the AT1 angiotensin receptor. J Biol Chem 1994;269:31378-31382.
35. Conlin PR, Moore TJ, Williams GH, Hollenberg NK: Rapid modulation of renal and adrenal responsiveness to angiotensin II. Hypertension 1993;22:832-838.
36. Douglas JG: Corticosteroids decrease glomerular angiotensin receptors. Am J Physiol 1987;252:F453-F457.
37. Bird IM, Word RA, Clyne C, Mason JI, Rainey WE: Potassium negatively regulates angiotensin II type 1 receptor expression in human adrenocortical H295R cells. Hypertension 1995;25:1129-1134.
38. Schirar A, Capponi A, Catt KJ: Elevation of uterine angiotensin II receptors during early pregnancy in the rat. Endocrinology 1980;106:1521.
39. Chen FCM, Printz MP: Chronic estrogen treatment reduces angiotension II receptors in the anterior pituitary. Endocrinology 1983;113:1503.
40. Schirar A, Capponi A, Catt KJ: Regulation of uterine angiotensin II receptors by estrogen and progesterone. Endocrinology 1980;106:5.
41. Re RN: Myocardial hypertrophy, angiotensin, and ACE inhibitors (review). Angiology 1993;44:875-881.
42. Kabour A, Henegar JR, Janicki JS: Angiotensin II (AII)-induced myocyte necrosis: role of the All receptor. J Cardiovasc Pharmacol 1994;23:547-553.
43. Weber KT, Sun Y, Cleutjens JPM: Structural remodeling of the myocardium postinfarction: potential mechanisms and influence of therapy. Cardiol Rev 1995;3: 53-65.
44. Gansevoort RT, de Zeeuw D, Shahinfar S, Redfield A, de Jong PE: Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease. J Hypertens 1994;12(suppl 2):S37-S42.
45. Wisgerhof M, Brown RD: Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension. J Clin Invest 1978;61:1456-1462.
46. Wisgerhof M, Brown RD, Hogan MJ, Carpenter PC, Edis AJ: The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism. J Clin Endocrinol Metab 1981;52:195.
47. Bonnardeaux A, Davies E, Jeunemaitre X, Féry I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F: Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994;24:63-69.
48. Kainulainen K, Perola M, Terwilliger J, Kaprio J, Koskenvuo M, Syvanen AC, Vartiainen E, Peltonen L, Kontula K: Evidence for involvement of the Type 1 angiotensin II receptor locus in essential hypertension. Hypertension 1999;33:844-849.
49. Bottari SP, de Gasparo M, Steckelings UM, Levens NR: Angiotensin II receptor subtypes: characterization, signaling mechanisms, and possible physiological implications (review). Front Neuroendocrinol 1993;14:123-171.
50. Stadtmauer LA, Rosen OM: Phosphorylation of exogenous substrates by the insulin receptor-associated protein kinase. J Biol Chem 1983;258:6682-6685.
51. Haberl RL, Decker PJ, Einhaupl KM: Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. Circ Res 1991;68:1621-1627.
52. Elliott ME, Goodfriend TL: Angiotensin and bradykinin interactions with phospholipids. Biochim Biophys Acta 1979;586:357-373.
53. Freer RS, Pappano AJ, Peach MJ, Bing KT, McLean MJ, Vogel SM, Sperelakis N: Mechanism of positive inotropic effect of angiotensin II on isolated cardiac muscle. Circ Res 1976;39:178-183.
54. Kenakin T: The classification of seven transmembrane receptors in recombinant expression systems. Am Soc Pharmacol Exp Ther 1996;48:413-451.
55. Goodfriend TL: Angiotensins: a family that grows from within (editorial comment). Hypertension 1991;17:139-140.